Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hirschowitz

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
The American Journal of Psychiatry|November 1, 1985
Down-regulation of central dopamine receptors in schizophreniaF P Zemlan, R J Hitzemann, J Hirschowitz, et al.
Psychopharmacology Bulletin|January 1, 1985
Plasma haloperidol levels and clinical response: confounding variablesM L Mavroidis, D L Garver, D R Kanter, et al.
Psychopharmacology|January 1, 1983
Clinical response and plasma haloperidol levels in schizophreniaM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Journal of Clinical Psychopharmacology|December 1, 1983
Thioridazine effect on desipramine plasma levelsJ Hirschowitz, J A Bennett, F P Zemlan, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1984
Impact of lithium therapy on core psychotic symptoms of schizophreniaF P Zemlan, J Hirschowitz, F J Sautter, et al.
The American Journal of Psychiatry|October 1, 1995
Predictors of response to lithium in patients with psychosesL W Schexnayder, J Hirschowitz, F J Sautter, et al.
Journal of Clinical Psychopharmacology|June 1, 1984
Clinical relevance of thiothixene plasma levelsM L Mavroidis, D R Kanter, J Hirschowitz, et al.
The Journal of Clinical Psychiatry|June 1, 1985
The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsyM B Scharf, D Brown, M Woods, et al.
The Journal of Clinical Psychiatry|September 1, 1984
Fluphenazine plasma levels and clinical responseM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Psychiatry Research|March 1, 1984
Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium responseR J Hitzemann, F Sautter, B Hitzemann, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
The American Journal of Psychiatry|November 1, 1985
Down-regulation of central dopamine receptors in schizophreniaF P Zemlan, R J Hitzemann, J Hirschowitz, et al.
Psychopharmacology Bulletin|January 1, 1985
Plasma haloperidol levels and clinical response: confounding variablesM L Mavroidis, D L Garver, D R Kanter, et al.
Psychopharmacology|January 1, 1983
Clinical response and plasma haloperidol levels in schizophreniaM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Journal of Clinical Psychopharmacology|December 1, 1983
Thioridazine effect on desipramine plasma levelsJ Hirschowitz, J A Bennett, F P Zemlan, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1984
Impact of lithium therapy on core psychotic symptoms of schizophreniaF P Zemlan, J Hirschowitz, F J Sautter, et al.
The American Journal of Psychiatry|October 1, 1995
Predictors of response to lithium in patients with psychosesL W Schexnayder, J Hirschowitz, F J Sautter, et al.
Journal of Clinical Psychopharmacology|June 1, 1984
Clinical relevance of thiothixene plasma levelsM L Mavroidis, D R Kanter, J Hirschowitz, et al.
The Journal of Clinical Psychiatry|June 1, 1985
The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsyM B Scharf, D Brown, M Woods, et al.
The Journal of Clinical Psychiatry|September 1, 1984
Fluphenazine plasma levels and clinical responseM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Psychiatry Research|March 1, 1984
Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium responseR J Hitzemann, F Sautter, B Hitzemann, et al.
Pageof 6